https://www.captis.com/wp-content/uploads/2021/04/fb_image-2028.jpeg12751920CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-04-22 05:07:022021-04-22 05:55:49Claritas and CMAX Clinical sign agreement for Phase 1 R-107 clinical study
https://www.captis.com/wp-content/uploads/2021/04/fb_image-596.jpeg12801920CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-04-21 02:08:392021-04-21 02:56:52Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
https://www.captis.com/wp-content/uploads/2021/04/fb_image-1453.jpeg12801920CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-04-20 01:12:422021-04-20 01:52:09Second indication of Sarclisa for relapsed multiple myeloma approved by EC
https://www.captis.com/wp-content/uploads/2021/04/fb_image-3250.jpeg12801920CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-04-16 02:13:262021-04-16 02:52:55GSK and Vir announce EMA review of VIR-7831 for early treatment of Covid-19
https://www.captis.com/wp-content/uploads/2021/04/fb_image-873.jpeg12721920CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-04-15 00:09:092021-04-15 00:57:25SciNeuro and Eli Lilly sign exclusive license agreement for alpha-synuclein in Greater China
https://www.captis.com/wp-content/uploads/2021/04/fb_image-2965.jpeg12801920CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-04-14 07:36:482021-04-14 07:59:56Trodelvy granted accelerated approval by USFDA for metastatic urothelial cancer
https://www.captis.com/wp-content/uploads/2021/04/fb_image-2587.jpeg12801920CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-04-14 00:02:562021-04-14 00:54:53Dr. Reddy’s secures EUA for Sputnik V in India